McIlrath & Eck’s BlackRock Capital Allocation Term Trust BCAT Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q1
$44.2K Buy
3,130
+1,969
+170% +$29K ﹤0.01% 577
2025
Q4
$16.4K Sell
1,161
-1,838
-61% -$26.6K ﹤0.01% 561
2025
Q3
$44.4K Buy
2,999
+2,719
+971% +$40.7K ﹤0.01% 347
2025
Q2
$4.24K Hold
280
﹤0.01% 746
2025
Q1
$4.03K Hold
280
﹤0.01% 759
2024
Q4
$4.24K Hold
280
﹤0.01% 782
2024
Q3
$4.61K Hold
280
﹤0.01% 756
2024
Q2
$4.59K Hold
280
﹤0.01% 725
2024
Q1
$4.67K Hold
280
﹤0.01% 731
2023
Q4
$4.19K Hold
280
﹤0.01% 707
2023
Q3
$4.06K Hold
280
﹤0.01% 695
2023
Q2
$4.27K Hold
280
﹤0.01% 703
2023
Q1
$4.24K Hold
280
﹤0.01% 694
2022
Q4
$3.88K Buy
+280
New +$3.95K ﹤0.01% 679

Other funds holding BCAT

McIlrath & Eck's BCAT Position: Q1 2026 in Review

McIlrath & Eck increased its BlackRock Capital Allocation Term Trust (BCAT) stake by 170% in Q1 2026, buying an estimated $29K and bringing the position to 3,130 shares worth $44.2K. The position accounts for ﹤0.01% of the portfolio, ranked #577.

McIlrath & Eck first reported a position in BCAT in Q4 2022 and has held it in 14 quarters since. The position peaked at $44.4K in Q3 2025. 100 funds tracked by Wall St. Rank hold BCAT as of Q1 2026.

  • McIlrath & Eck held 3,130 shares of BlackRock Capital Allocation Term Trust worth $44.2K as of Q1 2026.
  • McIlrath & Eck bought 1,969 BlackRock Capital Allocation Term Trust shares in Q1 2026, an estimated $29K.
  • BlackRock Capital Allocation Term Trust made up ﹤0.01% of McIlrath & Eck's portfolio in Q1 2026, its #577 holding.
  • McIlrath & Eck first reported a position in BlackRock Capital Allocation Term Trust in Q4 2022 and has held it in 14 quarters since.
  • McIlrath & Eck's BlackRock Capital Allocation Term Trust position peaked at $44.4K in Q3 2025.
  • 100 funds tracked by Wall St. Rank held BlackRock Capital Allocation Term Trust as of Q1 2026.

Based on McIlrath & Eck's 13F filing for Q1 2026, filed 19 May 2026.